2017
DOI: 10.5327/z1806-3144201700020009
|View full text |Cite
|
Sign up to set email alerts
|

Gel de Chamomilla Recutita para reação de pele em paciente submetido à quimiorradioterapia: relato de caso

Abstract: RESUMOO presente relato tem o objetivo de descrever o efeito do gel de Chamomilla recutita (C. recutita) em radiodermatite de paciente submetido à quimiorradioterapia -paciente do sexo masculino, com neoplasia de orofaringe, que fez uso do gel na concentração de 8,35% na região irradiada. A partir da 16ª sessão, o paciente apresentou radiodermatite Grau I, segundo escore Radiation Therapy Oncology Group (RTOG), caracterizada por leve eritema da região irradiada. A graduação foi mantida até o fi nal da radioter… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 5 publications
0
3
0
Order By: Relevance
“…Insufficient evidence was reported to support the use of urea, Xonrid, hydroactive colloid gel, and other interventions. 21 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 , 149 , 150 , 151 , 152 , 153 , 154 , 155 , 156 Growth factors and oral agents 9 (7) 1721 (78; 40-1142) Enzyme mixture (3); Other (6) Head and neck (5); Breast (2); Multiple (1); Cervical (1) ...…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Insufficient evidence was reported to support the use of urea, Xonrid, hydroactive colloid gel, and other interventions. 21 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 , 149 , 150 , 151 , 152 , 153 , 154 , 155 , 156 Growth factors and oral agents 9 (7) 1721 (78; 40-1142) Enzyme mixture (3); Other (6) Head and neck (5); Breast (2); Multiple (1); Cervical (1) ...…”
Section: Resultsmentioning
confidence: 99%
“…Natural and miscellaneous agents were assessed in 51 studies, of which 39 were RCTs 21 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 , 149 , 150 , 151 , 152 , 153 , 154 , 155 , 156 ( Appendix C, Table 5 ). The majority of interventions showed minimal or no benefit protecting against ARD in a randomized setting, including honey-based products, 125 , 126 vitamins, 129 , 130 chamomile-based cream, 141 calendula (marigold)-based products, 113 , 116 and products containing glutamine.…”
Section: Resultsmentioning
confidence: 99%
“…Third, it cannot alter or reduce the radiation action, that is, protecting the tumor from radiation damage. 13 In this context, Chamomilla recutita (L.) Rauschert, a plant with anti-inflammatory properties, [14][15][16][17] which is used in clinical practice as an infusion, has been investigated in the reduction of inflammation induced by radiation, and there is evidence showing its benefits on the intensity of inflammatory RT reactions 18,19 with no tumor protection. Associated with the healing effect and anti-inflammatory properties of chamomile the controlled release system present in the microparticles may decrease the incidence and severity of these injuries.…”
mentioning
confidence: 99%